1α, 25-dihydroxyvitamin D3 and all-trans-retinoic acid inhibit the growth of a lung cancer cell line

Anticancer Research

Volumn 16, Issue 5 A, 1996, Pages 2653-2659

  Higashimoto, Yuji ^a   Ohata, Masahiro ^a   Nishio, Kazuto ^b   Iwamoto, Yushiki ^a   Fujimoto, Hisashi ^a   Uetani, Kousaku ^a   Suruda, Tadatoshi ^a   Nakamura, Yoshinori ^a   Funasako, Masato ^a   Saijo, Nagahiro ^b  

^a WAKAYAMA MEDICAL UNIVERSITY   (Japan)

^b NATIONAL CANCER CENTER RESEARCH INSTITUTE   (Japan)

Author keywords

Calcitriol; Lung cancer; Retinoic acid; Retinoic acid receptor alpha; Vitamin D receptor

Indexed keywords

CALCITRIOL; CALCITRIOL RECEPTOR; MESSENGER RNA; RETINOIC ACID; RETINOIC ACID RECEPTOR;

ANTINEOPLASTIC ACTIVITY; ARTICLE; CELL GROWTH; COLORIMETRY; CONTROLLED STUDY; DRUG EFFECT; HUMAN; HUMAN CELL; LUNG CANCER; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SQUAMOUS CELL CARCINOMA;

ACTINS; ANTINEOPLASTIC AGENTS; CALCITRIOL; CELL DIVISION; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG SCREENING ASSAYS, ANTITUMOR; HUMANS; RECEPTORS, CALCITRIOL; RECEPTORS, RETINOIC ACID; RNA, MESSENGER; TRETINOIN; TUMOR CELLS, CULTURED;

EID: 10544254691     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (38)

1. Pike JW: Vitamin D3 receptors: structure and function in transcription. Annu Rev Nutr 11: 189-216, 1991.
2. Eisman JA, Barkla DH, and Tutton PJ: Suppression of in vivo growth of human cancer solid tumor xenografts by 1,25-dihydroxyvitamin D3. Cancer Res 47: 21-25, 1987.
3. Frampton RJ, Omond SA, and Eisman JA: Inhibition of human cancer cell growth by 1,25-dihydroxyvitamin D3 metabolites. Cancer Res 43: 4443-4447, 1983.
4. Abe E, Miyamura CM, Sakagami H, Takeda M, Konno K, Yamazaki T, Yshiki S, and Suda T: Differentiation of mouse myeloid leukemia cells induced by 1α ,25-dihydroxyvitamin D3. Proc Natl Acad Sci USA 78: 4990-4994, 1981.
5. Frampton RJ, Suva LJ, Eisman JA, Findlay DM, Moore GE, Moseley JM, and Martin TJ: Presence of 1,25-dihydroxyvitamin D3 receptors in established human cancer cell lines in culture. Cancer Res 42: 1116-1119, 1982.
6. Thomas GA, and Simpson RU: High performance liquid chromatography analysis of 1,25-dihydroxyvitamin D3 receptor in malignant cells. Correlation of effects on cell proliferation and receptor concentration. Cancer Biochem Biophys 8: 221-234, 1986.
7. Colston K, Colston J, Fieldsteel AH, and Feldman D: 1,25-dihydroxyvitamin D3 receptors in human epithelial cancer cell lines. Cancer Res 42: 856-859, 1982.
8. Roberts AB, and Sporn MB: Cellular biology and biochemistry of the retinoids. In: The Retinoids (Sporn MB, Roberts AB, and Goodman DS, eds). New York Academic Press, 1984, pp 210-286.
9. Marchok AC, Clark JN, and Klein-Szanto A: Modulation of growth, differentiation, and mucous glycoprotein synthesis by retinyl acetate in cloned carcinoma cell lines. J Natl Cancer I 66: 1165-1174, 1981.
10. Walter C, and Willett MD: Vitamin A and lung cancer. Nutr Rev 48: 201-211, 1990.
11. Geradts J, Chen JY, Russell EK, Yankaskas JR, Nieves L,.and Minna JD: Human lung cancer cell lines exhibit resistance to retinoic acid treatment. Cell Growth & Differentiation 4: 799-809, 1993.
12. Roth AD, Abele R, and Alberto P: 13-cis-retinoic acid plus interferon-alpha: a phase II clinical study in squamous cell carcinoma of the lung and the head and neck. Oncology 51: 84-86, 1994.
13. Schräder M, Bendik I, Andre MB, and Carlberg C: Interaction between retinoic acid and vitamin D signaling pathways. J Biol Chem 268: 17830-17836, 1993.
14. Umesono K, Murakami KK, Thompson CC, and Evans RM: Direct repeats as selective response elements for the thyroid hormone, retinoic acid, and vitamin D3 receptors. Cell 65: 1255-2266, 1991.
15. Evans RM: The steroid and thyroid hormone receptor superfamily. Science 13: 889-895, 1988.
16. Whitfield GK, Hsieh JC, Jurutka PW, Selznick SH, Haussler CA, MacDonald PN, and Haussler MR: Genonic actions of 1,25-dihydroxyvitamin D3. J Nutr 125: 1690S-1694S, 1995.
17. Freedman LP, Arce V, Fernandez RP. DNA sequences that act as high affinity targets for the vitamin D3 receptor in the absence of the retinoid X receptor. Mol Endocrinol 8: 265-273, 1994.
18. Mosmann T: Rapid colorimetric assay for cellular growth and survival: application and cytotoxicity assays. J Immunol Meth 65: 55-63, 1983.
19. Chomczynski P, and Sacchi N: Single-step method of RNA isolation by guanidinium thiocyanate phenol chloroform extraction. Anal Biochem 165: 156-159, 1987.
20. Amemiya Y, and Miyahara J: Imaging plate illuminates many fields. Nature 336: 89-90, 1988.
21. Kinoshita T, Imamura J, Nagai H, and Shimotohno K: Quantification of gene expression over a wide range by the polymerase chain reaction. Anal Biochem 206: 231-235, 1992.
22. Thomas GA, and Simpson RU: High performance liquid chromatography analysis of 1,25-dihydroxyvitamin D3 receptor in malignant cells. Correlation of effects on cell proliferation and receptor concentration. Cancer Biochem Biophys 8: 221-234, 1986.
23. Saulenas AM, Cohen SM, Key LL, Winter C, and Albert DM: Vitamin D and retinoblastoma. The presence of receptors and inhibition of growth in vitro. Arch Ophthalmol 106: 533-535, 1988.
24. Sandgren M, Danforth L, Plasse TF, and DeLuca HF: 1,25-dihydroxyvitamin D3 receptors in human carcinomas: A pilot study. Cancer Res 51: 2021-2024, 1991.
25. Vanderbilt JN, Miesfeld R, Maler BA, and Yamamoto KR: Intracellular receptor concentration limits glucocorcicoid dependent enhancer activity. Mol Endocrinol 1: 68-74, 1987.
26. Canningham D: Alfacalcidol as a modulator of growth of low grade non-Hodgkin's lymphoma. Br Med J 291: 1153-1155, 1985.
27. Hong WK, Endicott J, Itri LM, Doos W, Batsakis JG, Bell R, Fofonoff S, Byers R, Atkinson EN, Vaughan C, Thoth BB, Kramer A, Wimery IW, Skipper P, and Strong S: 13-cis retinoic acid in the treatment of oral leukoplakia. N Engl J Med 315: 1501-1505, 1986.
28. Clark RE, Lush CJ, Jacobs A, and Smith SA: Effect of 13-cis retinoic acid on survival of patients with myelodysplastic syndrome. Lancet 1: 763-765, 1987.
29. Meng-er H, Chen Y, Shu-rong C, Jin-ren C, Jia-Xiang L, Lin Z, Long-jun G and Zhen-yi W: Use of all-trans-retinoic acid in the treatment of acute promyelocytic leukemia. Blood 72: 567-572, 1988.
30. Pastorino U, Infante M, Maioli M, Chiesa G, Buyse M, Firket P, Rosmentz N, Clerici M, Soresi E, and Valentc M: Adjuvant treatment of stage I lung cancer with high-dose vitamin A. J Clin Oncol 11: 1216-1222, 1993.
31. Maxwell SA: Retinoblastoma protein in non-small cell lung carcinoma, cells arrested for growth by retinoic acid. Anticancer Research 14: 1535-1540, 1994.
32. Zhang XK, Liu Y, Lee MO, and Pfahl M: A specific defect in the retinoic acid response associated with human lung cancer cell lines. Cancer Research 54: 5663-5669, 1994.
33. Kalemkerian GP, Jasti RK, Celano P, Nelkin BD, and Mabry M: All-trans-retinoic acid alters myc gene expression and inhibits in vitro progression in small cell lung cancer. Cell Growth & Differentiation 5: 55-60, 1994.
34. Yu VC, Delscrt C, Andersen B, Holloway JM, Devary OV, Nä är AM, Kim SY, Boutin JM, Glass CK, and Rosenfeld MG: RXRß: A coregulator that enhances binding of retinoic acid, thyroid hormone, and vitamin D receptors to their cognate response elements. Cell 67: 1251-1266, 1991.
35. Leid M, Kastner P, Lyons R, Nakshatri H, Saunders M, Zacharewski T, Chen JY, Staub A, Gamier JM, Mader S, and Chambon P: Purification, cloning, and RXR identity of the Hela cell factor with which RAR of TR heterodimerizes to bind target sequences efficiently. Cell 68: 377-395, 1992.
36. Baker AR, McDonnell DP, Hughes M, Crisp TM, Mangelsdorf DJ, Haussler MR, Pike JW, Shine J. and O'Malley BW: Cloning and expression of full length cDNA encoding human vitamin D receptor. Proc Natl Acad Sci 85: 3294-3298, 1988.
37. Petkovich M, Brand NJ, Krust A, and Chamabon P: A human retinoic acid receptor which belongs to the family of nuclear receptors. Nature 303: 444-450, 1987.
38. Nudel U, Zakut R, Shani M, Neuman S, Levy Z, and Yaffe D: The nucleotide sequence of the rat cytoplasmic beta-actin gene. Nucleic Acids Res 11: 1759-1771, 1983.